Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
M&A
Biotech
2 cancer biotechs merge, creating global footprint
OncoC4 is taking AcroImmune—and its in-house clinical manufacturing capabilities—under its wing in an all-stock merger.
Gabrielle Masson
Sep 25, 2024 10:54am
PharmaLegacy snaps up preclinical CRO
Sep 16, 2024 3:50pm
Biopharma Q2 VC hit highest level since ’22, while M&A slowed
Aug 23, 2024 4:00am
Bayer pharma BD chief says group overhaul not slowing deals
Aug 15, 2024 2:30pm
Boehringer offers up to $1.3B for checkpoint inhibitor biotech
Jul 29, 2024 10:31am
AbbVie axes Alzheimer's program amid 'evolving landscape'
Jul 25, 2024 10:49am